Life Sciences Archive » January, 2011

Life Sciences - January, 2011

150 articles

• Judge Sanctions Roxane In Asacol Patent Suit
• False Patent Marking Defendants Gear Up For Round 2
• Judge Nixes Bayer Patent Suit Over Centocor's Simponi
• GSK Settles Wrongful Death Suit In Avandia MDL
• Genzyme, Sanofi Make Progress Toward Takeover Deal
• Novartis Sues Biogen, Others Over Gene Sequencing IP
• J&J Slammed With $482M Verdict In Stent Patent Suit
• Newly Bankrupt Angiotech Ends Merger Fight For $6M
• Novartis' Lescol Patent Enforceable, Judge Says
• ReNeuron To Pay Neuralstem To End Stem Cell Row
• Fed. Circ. Keeps Tyco Appeal Alive In Restoril Row
• US Sues Guidant Over Defective Defibrillators
• Baxter Hit With FDA Warning Over Puerto Rico Plants
• NY AG's Office Beefs Up Fraud-Fighting Units
• Dutch Court Nixes GSK Asthma Drug Patent
• Microsoft Asks High Court To Ease Patent Invalidation
• FDA Eyes AngioDynamics Over Surgical Knife Marketing
• HGS Sues Genentech To Protect Lupus Drug
• Roche Hit With Suit Over Blood Typing Patent
• Warner Chilcott, Roche Sue Teva Over Actonel ANDA
• AstraZeneca To Pay $20.5M In Ky. Medicaid Fraud Suit
• Fed. Circ. Trims Medtronic Surgery Patent Claims
• Pfizer Sanctioned Over Shoddy Witness Testimony
• FDA Suspects Link Between Breast Implants, Cancer
• FDA Set To Bump Defibrillators Up In Risk Class
• Kohl Resurrects 3 Antitrust Bills For New Congress
• Omnicare V. UnitedHealth: Premerger Best Practices
• Ortho Beats Watson Defenses In Birth Control IP Spat
• DOJ Eyes Defibrillators In Medicare Overbilling Probe
• 5th Circ. Affirms Dismissal Of Stryker Prosthetic Suit
• US To Weigh In On Legality Of False Marking Statute
• Merrill Lynch Settles SEC Fraud Charges For $10M
• NY Assembly Committee Advances E-Cigarette Ban
• AGs Ask 8th Circ. To Revive Drug Monopoly Suit
• Mylan Settles Suits Over Pfizer's Lipitor, Caduet
• 5 Ways To Draft Bulletproof Patent Claims
• Sullivan & Cromwell Reps Amgen In $1B BioVex Deal
• Mylan Faces Patent Suit Over Generic Comtan
• Protected Docs Still In Play In Generic Asacol Spat
• US Won $2.5B In Health Care Fraud Cases In '10: Study
• DC Circ. Won't Revisit Decision On E-Cigarettes
• Cravath Advises Novartis In $470M Genoptix Deal
• 9th Circ. Rules On Preemption In Generics Case
• Cialis Patent Suit Won't Go Before Supreme Court
• DOJ Ends J&J Blood Reagent Price-Fixing Probe
• Allergan Investor Suit Over Botox Deal Put On Hold
• Pfizer Silences Testimony On Short-Term Prempro Use
• Walgreens Ducks Fraud Action Over Pills In 7th Circ.
• Ex-Lehman Execs Want Savings Plan Action Tossed
• Fresenius Sues Zydus Over Generic PhosLo GelCaps
• St. Jude To Pay $16M To Settle FCA Suit
• Lilly Targets Pharma Cos. In Gemzar ITC Suit
• King Sues Intelliject Over EpiPen Patent Violation
• Funds Frozen In Seattle Genetics Insider Trading Case
• United, Merck Hit With Navy Communications IP Suits
• Bard Scores Partial Win In Covidien Patent Fight
• Celgene Ordered To Turn Over Thalomid Price Data
• Pfizer Sued Over Termination Of Wyeth Patent Pact
• Trumpf Wins Refund Of Surgical Lamp Duties
• Morgan Lewis Reps Perrigo In $540M Paddock Labs Buy
• Supreme Court Mulls Medicaid Clinics' Rights To Sue
• FDA Unveils Changes To Medical Device Review Process
• J&J Escapes Toxic Baby Shampoo Action
• Genetics Co. Sues 6 Labs Over DNA Test Patent
• 8th Circ. Revives Class Action Over KV Recalls
• Judge Finds Novo's Prandin Patent Invalid
• J&J Unit Recalls 43M Bottles Made In Pa. Plant
• Boston Scientific To Pay Up To $375M For Atritech
• Drug Cos. Try To Keep Cephalon Case Info Under Wraps
• Judge Sets Stage For Trial In Norvir Monopoly Case
• Supreme Court Weighs Class Rules In Baycol Case
• Mylan, Ethypharm Strike Deal In FazaClo Patent Spat
• $76M Mylan Suit Remanded Over Jurisdictional Issues
• GSK To Pay £2.2B Legal Bill For Avandia Suits
• High Court Won't Hear Apotex's Exclusivity Appeal
• Ex-Stryker Exec Tries To Nix Cover-Up Claim
• High Court To Hear Fight Over Calif. Medicaid Cuts
• Ciba, J&J End Acuvue Patent Row In Fed. Circ.
• Case Study: Matrixx Initiatives Inc. V. Siracusano
• EU Seeks Info On Drug Patent Deals From 2010
• Abbott Scores $16M Win In Suit Over Generic Tarka
• Sanofi Beats Back Apotex Generic In Uroxatral MDL
• Bankruptcy Appeals Court Says Qualia Can Avoid Liens
• FDA Urged To Boost Oversight Of Food Safety Claims
• Venable Lures FDA Regulatory Expert To DC Outpost
• Blue Shield Offers Up Calif. Rates For Review
• Watson, Teva Clash Over Seasonique In Fed. Circ.
• Sanofi Heart Drug Multaq Linked To Liver Failure
• Case Study: Microsoft Corp. V. I4i LP
• Judge OKs $4.75M Quigley Deal Over Asbestos Claims
• Shire Sues Alkem Over Fosrenol Patents
• Bayer Sues Sun Pharmaceutical Over Yaz Patents
• Trial Patient Sues Abbott Over Humira Cancer Risks
• Aventis Sues Sandoz Over Generic Taxotere
• FDA Limits Acetaminophen Use In Prescription Drugs
• Allergan Sues Sandoz Over Sanctura XR Patents
• Spire Sues Creganna Unit Over Catheter Flaws
• Ore. AG Says Phantom Recall Misled Consumers
• Ad Groups Fired Up Over Graphic Cigarette Labels
• Guidant To Pay $296M Penalty In Defibrillator Case
• Fen-Phen Lawyer Indicted For Insurance Fraud
• TriMed Resolves Stryker Suit Over Wrist Repair IP
• NPEs Reap Big Rewards In IP Actions: Study
• Novo Seeks To Toss Antitrust Claims in Prandin Suit
• Merck Unit EMD Faces False Patent Marking Suit
• Apotex Sues Forest Labs Over Generic Lexapro
• Sobering Developments In Health Care Exclusion
• Justices Mull Drug Disclosures In Matrixx Fraud Case
• CVS To Pay $1M To Bury Banned Pharmacist Case
• Ex-InterMune CEO Says Withheld Docs Clear His Name
• 7th Circ. Upholds Omnicare Antitrust Suit Dismissal
• Boston Scientific Bags $104M IP Arbitration Deal
• Post Ariad: Written Descriptions For Patents
• Judge Voids PDL Antibody Patent In MedImmune Suit
• US Backs Drugmakers In Supreme Court Pricing Suit
• AGs Push High Court To Hear Pay-For-Delay Drug Suit
• Amgen Wins Ban On Teva's Generic Version Of Sensipar
• FDA Aims To Bolster Industry Transparency
• Aurobindo, Wyeth Settle Fight Over Generic Effexor
• Judge Stands By $21M Jury Verdict In Sulindac Case
• Lilly, Xanodyne Hid Darvocet Risks, Suit Says
• Sanofi Targets Accord Over Generic Taxotere
• Navinta Faces New Suit Over Generic Naropin ANDA
• AAI Asks 8th Circ. To Revive FTC Drug Monopoly Suit
• House Advances Health Care Repeal Vote
• FDA Doesn't Have To Release Provenge Docs: 2nd Circ.
• Jenner & Block Snags Goodwin M&A Expert
• Judge Shuts Door On Medtronic ERISA Action
• SEC Backs Off Indicted Richards Layton IT Guy For Now
• First Lady Taps Former Skadden Atty As Chief Of Staff
• Shareholders Join Suits In XenoPort Stock Price Case
• HHS Warns Of Health Care Repeal Dangers
• Nycomed Calls On WilmerHale In Vanos Patent Suit
• Novartis Loses Bid To Toss $2.6M Zometa Award
• Supreme Court Patent Cases: Past And Pending
• GSK Loses Bid To Bar Testimony On Avandia Risks
• FDA Warns Invacare Over Electric Bed Fire Hazards
• FDA Tackles Food Safety As Funding Remains Uncertain
• Portuguese Court Upholds €3M Abbott Price-Fixing Fine
• False Marking Suit Survives Ranbaxy's Dismissal Bid
• IP Cases To Watch In 2011
• A 'Storm Warning' For The Reinsurance Industry
• FDA Deputy Commissioner To Resign For Md. Job
• PharmAthene, SIGA Fight Over Bioterror Defense Drug
• Mylan To Pay $65M To Bury Medicaid Inflation Claims
• Paul Weiss Reps Universal In $1.25B CVS Deal
• FTC Challenges Lundbeck Drug Monopoly In 8th Circ.
• Latency Periods And The Statute Of Limitations
• Lupin Strikes Deal In Suit Over Generic Lunesta
• Wyeth Hit With $1.5M Verdict In Prempro Case